MAR 23, 2021 6:00 AM PDT

AI Test Distinguishes Cancer Cells From Healthy Ones Based on Acidity Levels

WRITTEN BY: Tara Fernandez

Researchers have developed a new way of differentiating cancer cells from healthy ones—by how acidic they are. The novel diagnostic leverages artificial intelligence to provide answers in around half an hour, with a 95 percent accuracy rate.

“The ability to analyze single cells is one of the holy grails of health innovation for precision medicine or personalized therapy. Our proof-of-concept study demonstrates the potential of our technique to be used as a fast, inexpensive and accurate tool for cancer diagnosis,” explained professor Lim Chwee Tech, one of the test’s inventors from the National University of Singapore.

The test works like this: First, a pH-sensitive dye called bromothymol blue is applied onto patients’ cells maintained in cell culture dishes. Contact with the dye triggers a color change in cells, which varies depending on their acidity levels. Next, microscopes capture images of the cells. A machine-learning algorithm then analyzes the images and generates a report.

The pH inside cancer cells tends to be higher than that of healthy cells. This phenomenon occurs at the very early phases of cancer development and becomes amplified as it progresses.

“Unlike other cell analysis techniques, our approach uses simple, inexpensive equipment and does not require lengthy preparation and sophisticated devices,” said Lim, who added that artificial intelligence helps with boosting the screen’s accuracy and speed. “Furthermore, we can monitor and analyze living cells without causing any toxicity to the cells or the need to kill them. This would allow for further downstream analysis that may require live cells," Lim added.

The team is now exploring the potential of using the same technology to detect cancer cells suspended in blood. “One potential application for this would be in liquid biopsy where tumor cells that escaped from a primary tumor can be isolated in a minimally-invasive fashion from bodily fluids such as blood,” Lim commented.

 

Sources: NUS News, APL Bioengineering


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 05, 2021
Clinical & Molecular DX
Wearable Patch Senses Blood Vessel Blockages
AUG 05, 2021
Wearable Patch Senses Blood Vessel Blockages
The cardiovascular system is like a network of highways, filled with an estimated 25 trillion red blood cells that conti ...
SEP 06, 2021
Cancer
A New Biomarker to Personalize Breast Cancer Therapy
SEP 06, 2021
A New Biomarker to Personalize Breast Cancer Therapy
The American Cancer Society estimates that over 280,000 women in the United States will be diagnosed with breast cancer ...
OCT 01, 2021
Health & Medicine
Eppendorf Award 2022: Call for Entries
OCT 01, 2021
Eppendorf Award 2022: Call for Entries
Eppendorf Award 2022: Call for Entries The Eppendorf Award for Young European Investigators, endowed with 20,000 EUR, is ...
OCT 27, 2021
Microbiology
Think Outside the Box to Reduce Waste, Improve Productivity
OCT 27, 2021
Think Outside the Box to Reduce Waste, Improve Productivity
Are you looking for ways to streamline your prepared media delivery and inventory stock management systems in your micro ...
NOV 09, 2021
Clinical & Molecular DX
Device Scavenges Body Heat, Allows Crowds to Gather Safely
NOV 09, 2021
Device Scavenges Body Heat, Allows Crowds to Gather Safely
If efforts to maintain public safety amidst the ongoing pandemic have taught us one thing, it’s that we need bette ...
NOV 15, 2021
Health & Medicine
Alpha-synuclein as a Biomarker for Parkinson's Disease
NOV 15, 2021
Alpha-synuclein as a Biomarker for Parkinson's Disease
Parkinson’s disease (PD) is a widespread neurogenerative disorder that can significantly impact a person’s q ...
Loading Comments...